It's not me it's those comments coming from the company that fans the flames....:
"Not only does Botanix boast one of the most advanced dermatology pipelines globally, it is probably the most advanced cannabinoid clinical company in the world and is poised to leverage its dataset and clinical insights into a range of new opportunities" (the new Chairman,Dr Washer).......and.....“Everyone seems to be jumping into pharmaceuticals. All of these companies that raised lots of money for growing operations and extraction operations have figured out that that is called farming, and whoever is the lowest cost producer in the correct geography will win,” Mr Callahan said.
Imagine what'll happen once the herd realises they've been investing in low tech agrarian stocks...and this on the back of the news that makes their model even more obsolete:
https://www.nature.com/articles/s41586-019-0978-9
While leading commentators like Jim Cramer are pointing their huge audiences towards the actual 'ball' at play, others are late in voicing their concerns:
"Put another way, biology is difficult to engineer -- period -- no matter the amount of capital at a company's disposal. Will investing in dozens of projects allow these companies to finally deliver a profitable commercial product to the cannabis market? Or will smaller teams with a deep understanding of the science prove more successful?"
https://www.fool.com/investing/2019/03/01/will-cannabis-producers-ditch-greenhouses-for-bior.aspx
I guess the herd will try to recoup their losses by buying into a biotech developing scientifically tested prescription CBD drugs for multi-billion dollars markets? And that's as rare as a "good hair day" for Donald Trump.....hmm where would you find such a stock?
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-183
-
- There are more pages in this discussion • 257 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $707.4M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 31.5¢ | $240.1K | 747.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 298953 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 291247 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 423267 | 0.105 |
23 | 1189777 | 0.100 |
1 | 10111 | 0.099 |
1 | 50000 | 0.098 |
1 | 50000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 555657 | 10 |
0.115 | 560304 | 6 |
0.120 | 829451 | 14 |
0.125 | 1083838 | 12 |
0.130 | 498290 | 12 |
Last trade - 11.54am 25/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online